Our CAMP I study is the largest clinical study to date to evaluate the metabolism of children with autism spectrum disorder (ASD). It was funded by a research grant on autism from the National Institutes of Mental Health (NIMH). The details and results of this clinical study were published in a paper published in the scientific journal of Biological Psychiatry. This research was informed by our three earlier autism studies, which also investigated the connection between metabolism and autism.
Autism Clinical Studies
Children’s Autism Metabolome Project (CAMP) I
Identification of Amino Acid Dysregulation Subtypes
- Validated our NeuroPointDX autism spectrum disorder (NPDX ASD) blood test which may lead to an earlier ASD diagnosis for some children
- Compared a child’s comprehensive metabolic panel blood plasma sample results to their behavioral evaluation to identify differences in metabolism of children who were diagnosed with ASD
- Conducted at 8 clinical study sites, including some of the leading autism centers in the country
- Enrolled 1,100 children aged 18-48 months old
CAMP I Clinical Sites
This study was funded by a grant from the National Institutes of Mental Health and investments by the Nancy Lurie Marks Family Foundation and the Robert E. and Donna Landreth Family Fund. We are grateful to all of the children and families who participated in the CAMP I clinical study who helped us better understand ASD and develop the NeuroPointDX autism spectrum disorder (NPDX ASD) blood test.
UC-Davis MIND Institute
Dr. David Amaral – Principal Investigator
Nationwide Children’s Hospital
Dr. Daniel Coury – Principal Investigator
Massachusetts General Hospital
Lurie Center for Autism
Dr. Ann Neumeyer – Principal Investigator
Melmed Center
Dr. Raun Melmed – Principal Investigator
Monroe Carell, Jr. Children’s Hospital at Vanderbilt
Dr. Kevin Sanders – Principal Investigator
Dr. Allyson Cundiff – Principal Investigator
Children’s Hospital of Philadelphia (CHOP)
Dr. Amanda Bennett-Palladino – Principal Investigator
Arkansas Children’s Research Hospital
Dr. Richard Frye – Principal Investigator
(no longer at Arkansas Children’s Research Hospital)
Cincinnati Children’s Hospital Medical Center
Dr. Logan Wink – Principal Investigator
(no longer at Cincinnati Children’s Hospital)
We strive to improve the lives of children and families living with autism spectrum disorder and other neurological disorders by providing tools for earlier diagnosis and more precise treatment.
